News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current GENX market cap is 2.07M. The company's latest EPS is CAD -0.0742 and P/E is -0.40.
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 137k | 0 | 0 | 0 | 12k |
| Operating Income | -78k | -469k | -1.39M | -860k | -4.19M |
| Net Income | -164k | -718k | -1.65M | -1.07M | -4.4M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 40k | 5.35M | 4.77M | 4.25M | 223k |
| Total Liabilities | 82k | 490k | 755k | 1.05M | 1.36M |
| Total Equity | -42k | 4.86M | 4.01M | 3.2M | -1.14M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -130k | -195k | -428k | -220k | -220k |
| Investing | N/A | -8k | N/A | -3k | N/A |
| Financing | 20k | 868k | -129k | 93k | 223k |
| Market Cap | 2.07M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 150 |
| Price to Cash Ratio | 150 |
| Price to Book Ratio | -1.56 |
| Dividend Yield | - |
| Shares Outstanding | 59.22M |
| Average Volume (1 week) | 6.7k |
| Average Volume (1 Month) | 27.59k |
| 52 Week Change | -30.00% |
| 52 Week High | 0.075 |
| 52 Week Low | 0.015 |
| Spread (Intraday) | 0.01 (11.11%) |
| Company Name | Genix Pharmaceuticals Corp |
| Address |
10022 – 102 avenue grande prairie, alberta T8V 0Z7 |
| Website | https://www.genixpharm.com |
| Industry | food preparations, nec (2099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
